TT30, a Novel Human Protein Therapeutic, Selectively Modulates the Complement Alternative Pathway by Targeted Supplementation of Local Factor H Activity.
| Autor: | Holers, V. Michael *, Mazsaroff, Istvan *, Akana, Hillary *, Smith, Christopher G. *, Emlen, J. Woodruff *, Marians, Russell C. *, Horvath, Christopher J. * |
|---|---|
| Zdroj: | In Blood 20 November 2009 114(22):3021-3021 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|